We used in vitro translation and antibodies against phosphoserine and the eukaryotic initiation factors elF-4E, elF-4G, and elF-2a to examine the effects of global brain ischemia and reperfusion on translation initiation and its regulation in a rat model of 10 mm of cardiac arrest followed by resuscitation and 90 mm of reperfusion. Translation reactions were performed on postmitochondrial supernatants from brain homogenates with and without aurintricarboxylic acid to separate incorporation due to run-off from incorporation due to peptide synthesis initiated in vitro. The rate of leucine incorporation due to in vitro-initiated protein synthesis in normal forebrain homogenates was -~0.4 fmol of leucine/min/ 1.tg of protein and was unaffected by 10 mm of cardiac arrest, but 90 mm of reperfusion reduced this rate 83%. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blots of these homogenates showed that neither 10 mm of global brain ischemia nor 90 mm of reperfusion induced significant alterations in the quantity or serine phosphorylation of elF-4E. However, we observed in all 90-min-reperfused samples elF-4G fragments that also bound elF-4E. The amount of elF-2a was not altered by ischemia or reperfusion, and immunoblotting after isoelectric focusing did not detect serine-phosphorylated elF-2a in normal samples or in those obtained after ischemia without reperfusion. However, serine-phosphorylated elF-2a was uniformly present after 90 mm of reperfusion and represented 24 ± 3% of the elF-2a in these samples. The serine phosphorylation of elF-2a and partial fragmentation of elF-4G observed after 90 mm of reperfusion offer an explanation for the inhibition of protein synthesis.
initiation (Krause and Tiffany, 1993) . Formation of the translation-initiation complex requires the coordinated assembly of the ribosomal subunits, the mRNA to be translated, and the tRNA coding for the first amino acid (methionine in eukaryotic cells); this process is orchestrated by a family of proteins collectively known as eukaryotic initiation factors (eIFs). The elF-4 and eIF-2 complexes are believed to be the regulatory points for translation initiation (Redpath and Proud, 1994) . Most if not all mRNAs are introduced into the translation-initiation complex by the eIF-4 complex composed of eIF-4A [an ATP-dependent RNA helicase (Ray et al., 1985) 1 in association with eIF-4B (which accelerates eIF-4A's helicase activity), eIF-4E (which binds the mRNA m 7GTP cap), and eIF-4G [which provides docking sites for the aforementioned proteins (Lamphear et al., 1995) ]. The ternary complex, which contains eIF-2, is responsible for introducing methionyl-tRNA into the translation-initiation complex. In other model systems, the activity of these eIFs may be altered by proteolysis (Buckley and Ehrenfeld, 1987) or modification of the phosphorylation state of specific serine residues (Hershey, 1990) , either of which can result in suppressed protein synthesis. In this study we have used in vitro translation and antibodies against eIF-4E, eIF-4G, eIF-2a, and phosphoserine to examine the effects of global brain ischemia and reperfusion on translation initiation.
MATERIALS AND METHODS
Recombinant eIF-4E and the polyclonal antibody against it were gifts from Paul McDermott (Medical University of Reperfusion after global brain ischemia results in a prompt suppression of protein synthesis (Nowak et al., 1984) that is especially severe and prolonged in selectively vulnerable neurons (Hossman and Kleihues, 1973; Cooper et al., 1977; Dienel et al., 1980) and is likely due to alterations in translation South Carolina, Charleston, SC, U.S.A.). Purified eIF-2 and monoclonal antibody against eIF-2a were gifts from Susan Oldfield (University of Bristol, Bristol, U.K.). The antibody against phosphoserine was purchased from Sigma. An affinity-purified polyclonal antibody was commercially prepared (Research Genetics, Huntsville, AL, U.S.A.) against a conserved peptide sequence of eIF-4G (KKEAVGDLLDAF-KEVN) beginning at amino acid 327 in the human sequence. It has been shown that antibodies raised against this sequence react with authentic and recombinant eIF-4G and with the proteolytic fragments produced from eIF-4G by poliovirus infection in HeLa cells (Yan et al., 1992) ; this sequence is also near the eIF-4E binding site that resides somewhere between residues 319 and 479 (Lamphear et al., 1995) . All other chemicals were reagent grade.
All animal experiments were approved by our institutional review board and were conducted following the Guide for the Care and Use of Laboratory Animal Care (NIH publication no. 86-23, revised 1985) . Male Long-Evans rats weighing 300-400 g were anesthetized with ketamine (45 mg/kg i.m.) and xylazine (5 mg/kg i.m.). Femoral vascular access was established for arterial pressure monitoring and intravenous fluid and drug administration, and tile ECG was continuously monitored. Rectal core temperature was continuously monitored and maintained at 37.0-37.5°C.Experimental groups were (a) nonischemic controls (control), (b) 10 mm of cardiac arrest without reperfusion (10-I), and (c) 10 mm of cardiac arrest, resuscitation, and 90 mm of reperfusion (90-R).
Complete global brain ischemia was generated by circulatory arrest induced by thoracic compression (Edmonds et al., 1989; Wauquier et al,, 1989) and was confirmed by the complete loss of arterial pressure that occurred within 5 s. In the animals that were resuscitated, orotracheal intubation with a 14-gauge catheter was performed by direct laryngoscopy during the cardiac arrest. Resuscitation by chest compressions (200-300/mm) and mechanical ventilation (tidal volume, 1 ml/ 100 g; 40 breaths per minute; positive-endexpiratory pressure, 3 cm) with supplemental 02 was initiated after a 10-mm cardiac arrest period. The rate and depth of chest compressions were adjusted to maximize the arterial diastolic pressure. Epinephrine (doses of 100 jzg/kg i.v.) was given during resuscitation (average total dose, 200 ,ug/ kg). ECG and arterial pressure tracings were evaluated every 60 s for return of spontaneous circulation, defined as a systolic blood pressure of >60 mm Hg. The average time from onset of resuscitation to return of spontaneous circulation was 4 mm 20 s. Mechanical ventilation with supplemental 02 was provided for the entire postresuscitation period, and a dopamine infusion (10-20 ,ug/kg/min) was titrated as needed to maintain mean arterial pressure above 70 mm Hg. No animal recovered spontaneous respiration or consciousness during the 90-mm reperfusion period.
At the appropriate time, the brain was rapidly removed, and the forebrain was separated from the brainstem and cerebellum. One hemisphere was used for western blots and was homogenized on ice in 10 ml of ice-cold 50 mM Tris (pH 7.4), 20 mM EDTA, 20 mM EGTA, 1 mM dithiothreitol, 150 mM KC1, 0.23 mM phenylmethylsulfonyl fluoride, Ĩ .tg/mlaprotinin, 10 ptg/ml leupeptin, and 7 ,ug/ml pepstatin. The homogenate was centrifuged at 10,000 g for 30 mm at 4°C,and after an aliquot was obtained for protein concentration determination (by the Folin phenol reagent method), the supernatant was rapidly frozen and stored at -80°C.
For in vitro translation reactions, the other hemisphere was homogenized on ice in 2.5 volumes of ice-cold 50 mM HEPES (pH 7.54), 140 mM potassium acetate, 4mM magnesium acetate, 2.5 mM dithiothreitol, 10 ,ug/ml aprotinin, 4~cg/ml leupeptin, and 4~.tg/mlpepstatin. The homogenate was centrifuged at 10,000 g for 10 mm at 4°C, and the supernatant was assayed for protein concentration and stored as above.
For isoelectric focusing studies of eIF-2a, one brain hemisphere was homogenized on ice in 20 mM Tris (pH 7.5), 1 mM dithiothreitol, 5 mM magnesium acetate, 50 mM KC1, 1 mM EDTA, 2 mM EGTA, 100 mM NaF, 1~.tg/mlaprotinm, 10 ,ug/ml leupeptin, and 7~ig/m1 pepstatin (2.5 volumes/g wet weight of tissue). The homogenate was centrifuged at 10,000 g for 10 mm at 4°C, and the supernatant was assayed for protein concentration and stored at -80°C until needed. The other hemisphere was prepared for in vitro translation studies as described above.
In vitro translation was carried out by a modification of the method of Cosgrove and Rapoport (1986) . Translation reactions (final volume, 150 btl) contained 500 ,ug of brain protein and final concentrations of 50 mM HEPES (pH 7.54), 200 mM potassium acetate, 5 mM magnesium acetate, 50 ,ug/ml creatine phosphokinase, 100 ,uM each amino acid except leucine, 50 iM [ 3H] leucine (specific activity, 44 dpm/fmol), 2.5 mM dithiothreitol, and protease inhibitors (10~ig/ml aprotinin, 4~ug/ml leupeptin, and 4~.eg/ml pepstatin). The reactions were conducted at 37°Cand were initiated by addition of ATP, GTP, and creatine phosphate to a final concentration of 500 ,uM each. Aliquots removed at t 0 and periodically during the 10-mm reaction were spotted onto Whatman GF/A glass fiber filters prewetted with 3 ml of ice-cold 10% trichloroacetic acid containing 2 mg/mI nonradioactive leucine. The filters were washed in 5 ml of 10% trichloroacetic acid and 2 mg/ml unlabeled leucine for 15 mm and then heated in this solution at 90°Cfor 10 mm to hydrolyze charged tRNAs. After cooling to room temperature, the filters were washed twice for 10 mm in 5 ml of 5% trichloroacetic acid, then sequentially dehydrated with ethanol and acetone, dried, and counted for radioactivity in liquid scintillation fluid. Concurrent reactions were also carried out in 140 ,uM aurintricarboxylic acid (ATA), which blocks initiation (Fresno et al., 1976) , but not elongation (Stewart et al., 1971) , at the formation of the ternary complex and at the binding of mRNA to the small ribosomal subunit. In preliminary studies translation reactions were conducted with control brain homogenates to examine leucine incorporation in the presence of 0, 10, 30, 140, 280, and 420 1aM ATA; incorporation was progressively inhibited by ATA concentrations up to 140 ,uM but not further inhibited by greater ATA concentrations.
To calculate the amount of leucine incorporation due to translation initiated in vitro, the incorporation due to runoff was subtracted from total incorporation. That is, total incorporation includes both incorporation from peptides whose synthesis was initiated in vitro and incorporation due to elongation ofpeptides whose synthesis had been initiated in vivo. When 140 1iM ATA was included in the reaction mixture, the observed incorporation was taken to reflect only run-off. Therefore, the amount of incorporation from translation initiated in vitro was calculated by subtracting the data obtained at each time point with ATA from that obtained without ATA and was compared between experimental groups by ANOVA of repeat measures.
For western blots after sodium dodecyl sulfate (SDS) -polyacrylamide gel electrophoresis (PAGE), 50-jig protein samples were electrophoresed, transferred to nitrocellulose, immunoblotted with antibodies to eIF-2a, eIF-4E, or eIF-4G, and developed using enhanced chemiluminescence (ECL; Amersham). Serine phosphorylation was examined on the same membranes, after stripping (100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mMTris-HC1, pH 6.7), by using an antibody specific to phosphoserine. Positive identification of the serine-phosphorylated bands was obtained by overlaying the chemiluminescence films. Relative band densities were quantified by densitometry. In gels loaded with recombinant eIF-4E, 6 M urea was included in the 2X SDS-PAGE loading buffer to prevent aggregation. Membranes stained with antieIF-2a, anti-eIF-4E, and anti-eIF-4G were preblocked in 4% nonfat milk in 100 mM Tris (pH 7.4), 0.9% NaC1, and 1% Tween-20, and membranes developed with anti-phosphoserme were preblocked in 4% bovine serum albumin in Trisbuffered saline with Tween-20. Primary antibodies were used at a 1:1,000 dilution and incubated either at room temperature for 1 h (anti-eIF-2a and anti-eIF-4E) or at 37°Cfor 2 h (anti-eIF-4G and antiphosphoserine). The appropriate secondary antibody (mouse or rabbit) was used at a 1:10,000 dilution in a 30-mm incubation at room temperature in either 4% sheep serum (anti-mouse) or donkey serum (antirabbit).
The eIF-4E binding properties of protein bands identified by anti-eIF-4G antibody were examined by overnight incubation of a membrane in Tris-buffered saline with Tween-20 containing 1 jtg/ml recombinant eIF-4E and 0.5% bovine serum albumin followed by immunoblotting with antieIF-4E.
The phosphorylated and unphosphorylated forms of elF2a were separated by isoelectric focusing (Maurides et al., 1989) in polyacrylamide gels (3% T, 0.013% C) containing 2% CHAPS, 9 M urea, and 7.5% ampholines (pH 4.5-6.0; Sigma). Gels were prefocused sequentially at 200, 300, and 400 V for 20 mm each with the upper buffer tank (positive electrode) containing 0.01 M glutamic acmd and the lower buffer tank containing 0.05 M histidmne. Aliquots of 25 jig of protein in a loading buffer of 9 M urea, 3% ampholines, and 5% CHAPS were electrophoresed beginning at 500 V with a 50-V increase every 30 mmn up to 750 V and a final step to 1,000 V for 30 mm. The proteins were then transferred to nitrocellulose and immunoblotted with anti-eIF-2cx and antiphosphoserine as described above.
To determine if any endogenous eIF-2a kinase was active in our in vitro translation system, we used jy-32PIATP to look for increased eIF-2a phosphorylation. Immunoblotting of serial dilutions ofpostmitochondrial supernatant and purified eIF-2 indicated that the endogenous amount of elF2cr was "-6 ng/ 100 jig of protein in the postmitochondrial supernatant. The translation reaction conditions were modified to include 225 jig of protein from a 90-R postmitochondrial supernatant, exogenous eIF-2 containing a 2.5-fold excess of unphosphorylated eIF-2a, and [y-32P]ATP (final specific activity, 61 dpmlfmol of ATP). At 0, 5, 10, and 20 mm, aliquots were removed into an equal volume of 25 mM ice-cold EDTA, and the unreacted ATP was removed from the samples by passing the aliquots through Sephadex G-25. After SDS-PAGE (12.5%), the resulting membrane was spotted with serial dilutions of [y-32P] ATP ranging from 10 dpm to 20,000 dpm, and an autoradiograph was gener-
FIG.
1. In vitro translation in brain homogenates following ischemia and reperfusion. A: Leucine incorporation was examined during in vitro translation reactions using the postmitochondrial supernatant of rat forebrain homogenates from three nonischernie control animals (control) and from three animals subjected to a 10-mm cardiac arrest followed by resuscitation and 90 mm of reperfusion (90- 
RESULTS
Total leucine incorporation in control homogenates after 10 mm of in vitro translation was '--7.5 fmol of leucine/~.tgof homogenate protein (Fig. 1A) . As expected, total in vitro leucine incorporation in control brain homogenates was substantially inhibited in the presence of ATA (Fig. IA) ; the rate of incorporation due to in vitro initiation was '--0.4 fmol of leucine/ min//.tg of homogenate protein (Fig. 1B) . Ischemia alone had no significant effect either on leucine incor-
FIG. 2.
Western analysis of the amount and phosphorylation of elF-4E. A: Brain homogenates (n = 3 each group) derived from nonischemic controls (control; lanes 1-3), 10 mm of ischemia without reperfusion (lanes 4-6), and 10 mm of ischemia followed by 90 mm of reperfusion (lanes 7-9) were subjected to SOS-PAGE (12.5%) and immunoblotted with anti-elF-4E antibody. B: The same membrane was stripped, and a second western blot was obtained with antibody against serine phosphate. The relative concentrations of elF-4E and phosphorylated elF-4E [elF-4E(Pfl in the brain homogenates were characterized by densitometry. Neither 10 mm of ischemia (10-I) nor 90mm of reperfusion (90-R) was associated with significant alterations in the quantity of elF-4E (p = 0.43 by ANOVA) or its serine phosphorylation (p = 0.48 by ANOVA).
poration with and without ATA or on incorporation due to in vitro initiation (data not shown). In contrast, brain homogenates obtained after 90 mm of reperfusion demonstrated a substantial reduction in total leucine incorporation (Fig. 1A) and including ATA in these reactions produced little further reduction in total leucine incorporation. In the 90-min-reperfused samples, the incorporation at 10 mm of reaction time due to in vitro initiation was reduced 83% in comparison with controls ( Fig. IB ;p = 0.01 by ANOVA of repeat measures). These observations confirm that our model of global brain ischemia and reperfusion by cardiac arrest and resuscitation is generating reperfusion-associated inhibition of protein synthesis similar to that previously observed in models that used vascular occlusion to induce ischemia (Hossman and Kleihues, 1973; Cooper et al., 1977; Dienel et al., 1980; Nowak et al., 1984) .
The antibody against eIF-4E identified a single band migrating at the appropriate Mr for elF-4E ( Fig. 2A) .
There was no signal detected if preimmune serum was substituted for the antibody or if the antibody was prebiocked with recombinant eIF-4E. Neither 10 mm of cardiac arrest nor 90 mm of reperfusion was associated with significant changes in the relative quantity or serine phosphorylation state of eIF-4E ( Fig. 2B ; p = 0.43 and 0.48, respectively, by ANOVA). We have recently reported evidence of loss of eIF-4E associated with 20 mm of decapitation ischemia after haiothane anesthesia (Neumar et al., 1995) ; however, in the present study successful cardiac resuscitation required us to use a different anesthetic regimen and a cardiac arrest duration of 10 mm. Under these conditions we do not observe loss of eIF-4E.
The antibody against eIF-4G identified one predominant band at 220 kDa in control samples, as expected (Yan et al., 1992) . After 10 mm of ischemia one of the three brain homogenates demonstrated a marked signal increase in bands with molecular masses of 90, 69, 54, 43, and 38 kDa; these bands were uniformly prominent in all reperfused samples (Fig. 3) . These signals were ablated by prebiocking the primary antibody with the antigenic peptide. The elF-4E binding property of eIF-4G (Buckley and Ehrenfeld, 1987 ) and the proximity of our antigenic epitope to the eIF-4E
binding site lead to the prediction that some of the additional bands identified by our eIF-4G antibody might also bind eIF-4E. Therefore, we examined the apparent fragments of eIF-4G (Fig. 4 , left two lanes) for their ability to bind eIF-4E. After stripping, this membrane was first inimunoblotted for eIF-4E, which produced no signal (data not shown; the 25-kDa elF-4E runs off this 6% gel). However, after this membrane was restripped, incubated in elF-4E, and again immunoblotted for eIF-4E (Fig. 4 , right two lanes), the prominent elF-4G fragments consistently seen after reperfusion, with the exception of the band at 54 kDa, demonstrated eIF-4E binding activity. Further work   FIG. 3 . Western blot examination of elF-4G following brain ischemia and reperfusion. Brain homogenates (n = 3 each group) derived from nonischemic controls (control), 10 mm of ischemia without reperfusion (10-I), and 10 mm of ischemia followed by 90 mm of reperfusion (90-R) were subjected to SDS-PAGE (6%) and immunoblotted with anti-elF-4G antibody. Densitometry does not identify a significant loss of eIF-4G (migrating at 220 kDa; p = 0.28 by ANOVA), but the appearance of immunoreactive fragments suggests partial fragmentation of elF-4G.
proteins phosphorylated during the translation reaction in 90-R samples, the autoradiogram showed several bands with radioactivity corresponding to 10,000-20,000 dpm. However, the radioactivity overlying the eIF-2a bands, identified by immunoblot, was '-~50dpm (<1 fmol) and did not increase across the time course of the reaction. Because there was -'9 ng (260 fmol) of eIF-2a in each lane, this indicates that <0.4% of the eIF-2a could have undergone labeling in the reaction and argues against the presence of the active kinase in our 90-R brain homogenates.
DISCUSSION

FIG.
4. Western examination of the elF-4E binding properties of the elF-4G fragments. Duplicate samples of a brain homogenate with elF-4G fragments were immunoblotted with anti-elF-4G antibody (left two lanes). After this membrane was stripped, immunoblotting with anti-elF-4E antibody alone did not generate a signal (data not shown). However, after this membrane was restripped, incubated in elF-4E, and again immunoblotted for elF-4E (right two lanes), the prominent eIF-4G fragments consistently seen after reperfusion (Fig. 3) , with the exception of the band at 54 kDa, demonstrated elF-4E binding activity.
will be needed to characterize the respective contributions of events occurring during ischemia and reperfusion to production of these apparent eIF-4G fragments. SDS-PAGE and immunoblotting indicated that phosphoserine accumulated on eIF-2cr during reperfusion ( Fig. 5A and B) . This was confirmed by isoelectric focusing and immunoblotting; in this experiment the antibody against eIF-2cr identified, in samples obtained from controls and after 10 mm of ischemia without reperfusion, a single band that comigrated with pure eIF-2a. However, all 90-R samples displayed a doublet band response for eIF-2a, with the second band displaced toward more acidic pH, an expected consequence of phosphorylation (Fig. 5C) , and serine phosphorylation of the upper band was confirmed by immunostaining with antiphosphoserine antibody (Fig.  5D) . No detectable serine-phosphorylated eIF-2a was seen in control or 10-I samples. The total eIF-2a signal was not different among the groups (p = 0.63 by ANOVA), but densitometry of the isoelectric focusing results revealed that 24 ±3% of eIF-2cr is serinephosphorylated in the 90-R samples.
The increased eIF-2a phosphorylation does not appear to result from an active endogenous kinase in 90-R isolates. When [y-32P]ATP was used to label
Our results are consistent with previous reports of inhibited protein synthesis associated with reperfusion after global brain ischemia. We observed a profound reperfusion-induced inhibition of translation initiation during in vitro translation by brain homogenates obtained after 90 mm of reperfusion following a 10-mm cardiac arrest. Furthermore, we identified two potentially important reperfusion-associated alterations of initiation factors, the appearance of fragments of elF-
FIG. 5.
Western blot analysis of the amount and serine phosphorylation of elF-2a. Postmitochondrial supernatants of brain homogenates (n = 3 each group) derived from nonischemic controls (lanes 1-3) , 10 mm of ischemia without reperfusion (lanes 4-6), and 10 mm of ischemia followed by 90 mm of reperfusion (90-A; lanes 7-9) were subjected to SOS-PAGE (A and B) and isoelectric focusing PAGE (C and D; pH increases toward the bottom), which separates the phosphorylated and unphosphorylated forms of eIF-2a. After transfer, the membranes were developed with anti-elF-2a (A and C), stripped, and restamned with antiphosphosermne (B and D) antibodies. Lane S in blot A is the unphosphorylated cr-subunit of purified elF-2. The total elF-2a signal is not different among the groups (A and C). After 90 mm of reperfusion there is a prominent serinephosphorylated band (B, arrow) that exactly overlies the elF-2a band in A. With isoelectric focusing, elF-2a was resolved into two bands only in 90-A samples (C), and only the upper band gave a positive signal for phosphoserine (D, arrow) . Serinephosphorylated elF-2a (C, upper band) seen only after 90 mm of repertusion represents 24 ±3% of the total elF-2a signal.
4G and the serine phosphorylation of eIF-2a, either of which may contribute substantially to the inhibition of translation initiation seen during reperfusion.
Fragmentation of eIF-4G is associated with a pronounced loss of translation competence in poliovirusinfected HeLa cells (Etchison et al., 1982) . Although our experiments did not directly address the cause of the formation of the fragments, eIF-4G is a substrate for the calcium-activated protease j,t-calpain (Wyckoff et al., 1990) . The degradation bands we observed at 90 and 69 kDa are consistent in size with the calciuminduced eIF-4G degradation products observed by Wyckoff et al. (1990) , and we recently reported evidence of ji-calpain activation during global brain ischemia (Neumar et al., 1996) . Others have shown that eIF-4G fragments can bind eIF-4E (Buckley and Ehrenfeld, 1987) . This raises the possibility that eIF-4G fragments containing the eIF-4E binding site might compete with intact eIF-4G for available eIF-4E, thereby diminishing the rate of translation initiation. Experiments are needed to exarr'ine the effects of brain ischemia and reperfusion on the kinetics of formation of the eIF-4E/eIF-4G complex.
However, the presence of eIF-4G fragments may not be sufficient to account for the pattern of protein synthesis suppression seen in the selectively vulnerable neurons during reperfusion. Although these neurons generate large amounts of mRNA for the 70-kDa heat shock protein (HSP-70) during early reperfusion, this protein is essentially not synthesized by vulnerable neurons (Nowak, 1990; Nowak et al., 1990) . JoshiBarve et al. (1992) depleted eIF-4E and eIF-4G in HeLa cells by introducing antisense nucleotides and noted that several HSPs, including HSP-70, continued to be translated despite a dramatic reduction in total protein synthesis. This suggests that inhibition of formation of the eIF-4 complex is insufficient to account for the lack of HSP-70 synthesis in the selectively vulnerable neurons during reperfusion and that other alterations affecting translation initiation must be present.
Serine phosphorylation of eIF-2cr results in suppression of translation initiation that is independent of any message specificity and is thus a more likely explanation for the generalized inhibition of translation than is fragmentation of eIF-4G. Each initiation cycle requires the regeneration of active eIF-2 by exchange of an eIF-2-bound GDP for a GTP. This process is catalyzed by eIF-2B, which is competitively inhibited by eIF-2 that has been serine-phosphorylated on its asubunit (Rowlands et al., 1988) . Burda et al. (1994) recently reported evidence of phosphorylation of elF2a after brain ischemia and reperfusion, but they used a vessel ligation model that generates severe but incomplete ischemia, did not separate the effects of the period of incomplete ischemia from those of the period of reperfusion, and did not examine initiation-dependent translation. Our results extend their work and mdicate that serine phosphorylation of eIF-2cx does not occur during cardiac arrest but rather develops during reperfusion and is associated with a severe inhibition of translation initiation in brain homogenates from the same animals.
A complex consisting of eIF-2, GTP, and tRNA TMCt (the ternary complex) must be formed during each cycle of translation initiation. Hu and Wielock (1993) found that after reperfusion, formation of this complex was diminished, and they attributed this to reduced eIF-2B activity. However, Burda et al. (1994) presented evidence suggesting that the observed reduction in eIF-2B activity could be explained by competitive inhibition by a-subunit-phosphorylated eIF-2. The affinity of eIF-2B for a-subunit-phosphorylated eIF-2 is 150-fold greater than for unphosphorylated eIF-2 (Rowlands et al., 1988) , and the brain has about five times more eIF-2 than eIF-2B (Alcázar et al., 1995) . Thus, we would expect eIF-2B to be sequestered effectively from participating in the GTP-exchange reaction when '--'20% of brain eIF-2a is phosphorylated. In agreement with this, we found -=24% of the eIF-2a to be phosphorylated afteJ 90 mm of reperfusion, and this was associated with an 83% reduction in initiationdependent protein synthesis.
There are two known eIF-2a kinases in higher eukaryotes, the hemin-regulated inhibitor kinase and the double-stranded RNA-activated kinase, and activation of either of these could be responsible for the increase in serine phosphorylation seen on eIF-2cx at 90 mm of reperfusion. In reticulocytes the hemin-regulated inhibitor kinase is stimulated by free arachidonate (Rotman et al., 1992) or lipid hydroperoxides (DeHerreros et al., 1985) . In vivo the selectively vulnerable neurons display during ischemia the highest levels of free fatty acids, such as arachidonate (Umemura, 1990) , and during reperfusion the highest levels of lipid peroxidation products (Rosenthal et al., 1992; White et al., 1993) . It is interesting that a cDNA with 82% sequence homology to reticulocyte hemmn-regulated inhibitor kinase has recently been cloned from rat brain, expressed in Escherichia co/i, and shown to encode a protein that is a hemin-regulated eIF-2a kinase (Mellor et al., 1994) . RNA-activated kinase (Proud, 1995) could also he responsible for accumulation of phosphorylated eIF-2a during reperfusion because this kinase is activated by arachidonate-induced depletion of Ca2~from the endoplasmic reticulum (Prostko et al., 1995) , and this leads to phosphorylation of eIF-2ct and inhibition of translation (Srivastava et al., 1995) . Our experiment in which eIF-2a was not labeled by I I 32P I -ATP in homogenates obtained after 90 mm of reperfusion argues against persistent kinase activity during reperfusion. We note that the brain kinase responsible for eIF-2a phosphorylation could be activated either during ischemia or during reperfusion because a kinase activated during ischemia would not manifest its activity until ATP again became available. Experiments are .1. Neurochem., Vol. 67, No. 5, 1996 needed to search for and identify the active eIF-2cr kinase in brain homogenates obtained after various periods of ischemia or brief reperfusion.
Although a kinase must be involved, the increase in eIF-2cr phosphorylation might also reflect decreased phosphatase activity. For example, Kimball et al. (1991) observed that decreased phosphatase activity against phosphorylated eIF-2cr was responsible for its accumulation and translation inhibition subsequent to amino acid starvation in liver. All eukaryotic cells appear to contain just four types of serine phosphatases [designated PP1, PP2A, PP2B, and PP2C (Cohen, 1989) ]. Although all four types have been identified in brain, in vitro eIF-2a is a substrate only for PPI and PP2A (Ingebritsen and Cohen, 1983; Redpath and Proud, 1990) . Thus, studies of both the kinases and phosphatases involved in regulating phosphorylation of eIF-2a will be required to gain further insight into the causes of the enhanced eIF-2a phosphorylation we have observed.
